Capital Advisors Inc Eli Lilly & CO Transaction History

Capital Advisors Inc

$4.86 Billion
Q3 2024

A detailed history of Capital Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Advisors Inc holds 5,687 shares of LLY stock, worth $4.35 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,687

Previous 4,546 25.1%

Holding current value

$4.35 Million

Previous $4.12 Million 22.43%

% of portfolio

0.1%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$772.14 - $960.02 $881,011 - $1.1 Million	1,141 Added 25.1%	5,687 $5.04 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $92,058 - $115,448	127 Added 2.87%	4,546 $4.12 Million
Q1 2024 Apr 29, 2024	BUY	$592.2 - $792.28 $275,965 - $369,202	466 Added 11.79%	4,419 $3.44 Million
Q4 2023 Jan 29, 2024	BUY	$525.19 - $619.13 $297,782 - $351,046	567 Added 16.75%	3,953 $2.3 Million
Q3 2023 Oct 24, 2023	BUY	$434.7 - $599.3 $46,947 - $64,724	108 Added 3.29%	3,386 $1.82 Million
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $144,504 - $193,219	412 Added 14.38%	3,278 $1.54 Million
Q1 2023 Apr 19, 2023	BUY	$310.63 - $364.82 $22,675 - $26,631	73 Added 2.61%	2,866 $984,000
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $21,222 - $24,728	66 Added 2.42%	2,793 $0
Q3 2022 Oct 17, 2022	SELL	$296.48 - $337.87 $5,929 - $6,757	-20 Reduced 0.73%	2,727 $881,000
Q2 2022 Jul 15, 2022	BUY	$278.73 - $327.27 $5,574 - $6,545	20 Added 0.73%	2,747 $891,000
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $19,009 - $23,624	81 Added 3.06%	2,727 $781,000
Q4 2021 Jan 27, 2022	SELL	$224.85 - $279.04 $22,934 - $28,462	-102 Reduced 3.71%	2,646 $730,000
Q3 2021 Oct 25, 2021	SELL	$221.6 - $272.71 $44,098 - $54,269	-199 Reduced 6.75%	2,748 $635,000
Q2 2021 Aug 02, 2021	BUY	$180.55 - $233.54 $68,428 - $88,511	379 Added 14.76%	2,947 $676,000
Q1 2021 May 25, 2021	SELL	$164.32 - $212.72 $19,225 - $24,888	-117 Reduced 4.36%	2,568 $480,000
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $156,552 - $207,156	1,200 Added 80.81%	2,685 $453,000
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $11,990 - $13,868	82 Added 5.84%	1,485 $219,000
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $191,397 - $230,344	1,403 New	1,403 $214,000
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $297,976 - $350,740	-2,677 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $42,360 - $47,456	400 Added 17.57%	2,677 $309,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $85,860 - $107,310	-1,000 Reduced 30.52%	2,277 $244,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $17,803 - $19,759	-231 Reduced 6.58%	3,277 $280,000
Q2 2017 Aug 09, 2017	BUY	N/A	3,508	3,508 $289,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $727B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors Inc with notifications on news.

Account

Capital Advisors Inc Eli Lilly & CO Transaction History